Disclosure in pursuance to regulation 30 and other applicable regulations of Listing obligation and Disclosure requirements, Regulation 2015 for receiving of purchase order
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.1 pts less than Nifty Microcap 250 and 2.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Asston Pharmaceuticals has received a significant purchase order worth Rs 6,52,00,000 (Rs 6.52 crore including GST) from a leading domestic pharma company for the supply of various pharma products. The order is to be executed within 60 days, with payment terms of 20% advance and the balance on delivery. The order has no related party implications and the promoters have no interest in the awarding entity.
Positive short-term revenue visibility as the Rs 6.52 crore order provides confirmed business over the next two months, though the order size is modest. No material impact on shareholder structure or pricing power since this is a routine supply contract with an unrelated domestic client.